ASCO GU

ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
Fri, 02/17/23 - 09:36 am
ASCO GU
Pfizer
Astellas
Xtandi
prostate cancer
Merck's Keytruda Plus Eisai's Lenvima Could Open New Standard of Care in Renal Cancer
BioSpace
Tue, 02/16/21 - 11:12 am
Merck
ASCO GU
Keytruda
Eisai
Lenvima
renal cell carcinoma
ASCO GU: Bristol Myers touts first-in-class Opdivo win in muscle-invasive bladder cancer
Fierce Pharma
Tue, 02/9/21 - 01:02 pm
ASCO GU
Bristol-Myers Squibb
Opdivo
muscle-invasive urothelial carcinoma